By Business/Source
Currency:CNY
2025/FY
Stock NameRevenueRatio
销售生物制药产品5.77B86.62%
Research and development services619.14M9.29%
授权许可收入257.77M3.87%
Other12.24M0.18%
来自经营租赁的总租金收入2.87M0.04%
By Product
Currency:CNY
2025/FY
Stock NameRevenueRatio
销售生物制药产品5.77B86.62%
Research and development services619.14M9.29%
授权许可收入257.77M3.87%
Other12.24M0.18%
来自经营租赁的总租金收入2.87M0.04%
By Country/Region
Currency:CNY
2025/FY
Stock NameRevenueRatio
China Mainland5.78B86.73%
North America465.47M6.98%
Europe275.8M4.14%
亚太区(不包括中国大陆)116.01M1.74%
South America27.58M0.41%
